Is Amgen Still a Top Dividend Stock? | The Motley Fool

Dec 5, 2024 · Financial metrics paint an encouraging picture. Amgen's generous 3.23% dividend yield essentially matches its peer group average of 3.28%. Moreover, the biotech's third-quarter cash flow bodes ...

CouponFollow Extension

23%
OFF

Is Amgen Still A Top Dividend Stock? | The Motley Fool

2 weeks from now

fool.com

$149
OFF

Is Amgen Stock A Buy For Income Investors? | The Motley Fool

2 weeks from now

The Thousand Oaks, California-based company has established itself as a leading pharmaceutical business since its founding in 1980. Amgen's $149 billion market capitalizationmakes it one of the largest pharmaceutical companies in the world. Unsurprisingly, the company has a portfolio of more than two dozen drugs spread out across therapy areas like...

fool.com

50%
OFF

Amgen Surpasses Q4 Earnings Forecasts | The Motley Fool

2 weeks from now

4 days ago · The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy. Stocks Mentioned. Amgen. AMGN. $307.81 (6.50%) $18.79 ... Is Amgen Still a Top Dividend …

fool.com

05%
OFF

Amgen (AMGN) Q4 2024 Earnings Call Transcript - The Motley Fool

2 weeks from now

2 days ago · The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy. Stocks Mentioned. Amgen. AMGN. $289.02 (0.05%) $0.15 ... Is Amgen Still a Top Dividend …

fool.com

9%
OFF

Is Amgen Still A Top Dividend Stock? - AOL

2 weeks from now

Dec 5, 2024 · Still, Amgen's elevated payout ratio may mean more modest hikes to the program in the near term. Speaking to this point, the biotech has boosted its dividend by 13.9% on …

aol.com

9%
OFF

Is Amgen A Good Dividend Stock To Buy Right Now? - Yahoo …

2 weeks from now

Jan 29, 2024 · At the moment, Amgen's forward dividend yield is 2.9%. That puts it well above the broader market's average dividend yield of 1.5%, but still a bit short of what one would …

yahoo.com

07%
OFF

Amgen: Multiple Strengths, But The Valuation Is A Concern

2 weeks from now

16 hours ago · Despite Amgen's rising share price, the dividend yield is still above its 5-year average of 3.07%. The forward yield is now about 3.1% after the recent price gain after …

seekingalpha.com

310%
OFF

2 Excellent Dividend Stocks To Buy On The Dip - Yahoo Finance

2 weeks from now

Dec 23, 2024 · And since it split from Abbott in 2013, AbbVie has increased its dividend by 310%. The stock's forward yield is now around 3.8%, compared to the S&P 500's average of 1.3%. …

yahoo.com

2%
OFF

5 Top Stocks To Buy In February - The Motley Fool

2 weeks from now

4 days ago · Colgate-Palmolive may not be the flashiest company, but it is a reliable dividend stock and a top performer in its industry. With a yield of 2.2%, risk-averse investors should …

fool.com

$1000
OFF

2 Top Dividend Stocks To Buy If You Have $1,000 To Invest

2 weeks from now

4 days ago · Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More 2 Top …

fool.com

$500
OFF

The Motley Fool: An Inside Look At Amgen’s Fall - Dallas News

2 weeks from now

5 days ago · Based on all those factors, a $500 stock could actually be more of a bargain than a $10 stock. To see some stocks Motley Fool analysts have recommended, try our “Stock …

dallasnews.com

$50
OFF

Amgen's Broad Portfolio Strength And Wide Moat Should

2 weeks from now

2 days ago · Amgen's nearly $50 billion in net debt (as of the end of 2024) was built despite strong free cash flows from the business, as management prioritized distributions (in the form …

morningstar.com

5%
OFF

This Top High-Yielding Dividend Stock Continues To Generate …

2 weeks from now

6 days ago · Powerful growth still ahead. ... 5 Top Dividend Stocks Yielding More Than 5% to Buy in 2025. ... 903%. Premium Investing Services. Invest better with The Motley Fool. Get stock …

fool.com

12%
OFF

Earnings Miss? Amgen’s Dividend Still A Bright Spot - Nasdaq

2 weeks from now

2 days ago · Amgen made that list in 2024 and has a yield of 3.12% heading into earnings. The dividend also has annualized 3-year dividend growth of more than 8.5%, more than 50% …

nasdaq.com

FAQs about Is Amgen Still a Top Dividend Stock? | The Motley Fool Coupon?

Is Amgen a good dividend growth stock?

Amgen has increased its payouts by 201% in the past decade, and its forward yield is now around 3.7%. This is an excellent dividend growth stock to buy and hold. Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie and Abbott Laboratories. ...

Is Amgen (Amgen) a buyable stock?

Amgen's revenue and profits rose in Q2. The company's market-smashing dividend has growth ahead of it. The stock is priced at a buyable valuation. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. ...

Is Amgen a good stock to buy ahead of FED rate cuts?

Therefore, Amgen's combination of above-average yield, a strong growth profile, and a compelling valuation make its stock worth considering ahead of the Fed's anticipated rate cuts in 2025. George Budwell has no position in any of the stocks mentioned. The Motley Fool recommends Amgen. The Motley Fool has a disclosure policy. ...

Is Amgen stock overvalued?

Portfolio Insight's blended fair value model, combining the P/E ratio and dividend yield, estimates a fair value of $310.33 per share. The two-model average is ~$299.37, indicating that Amgen is overvalued at the current price. ...

Are AbbVie & Amgen a good stock to buy?

Both have grown their dividends at a good clip over the past decade. AbbVie (ABBV 0.99%) and Amgen (AMGN 0.75%) have a lot in common. They are both leading drugmakers and have strong dividend track records. Both also recently saw their shares fall significantly in one day, following unimpressive clinical data for otherwise promising candidates. ...

Should you buy Amgen (Amgen) as a pure-play income stock?

The only major concern is the drugmaker's ability to return to healthy levels of top-line growth in the back half of the decade, and that's arguably a plus for its prospects as a pure-play income stock. Amgen, after all, has a fairly low trailing-12-month payout ratio of 54%, meaning that its dividend is on safe ground. ...